1. Home
  2. UG vs PLUR Comparison

UG vs PLUR Comparison

Compare UG & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United-Guardian Inc.

UG

United-Guardian Inc.

N/A

Current Price

$6.25

Market Cap

30.2M

ML Signal

N/A

Logo Pluri Inc.

PLUR

Pluri Inc.

N/A

Current Price

$3.06

Market Cap

33.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UG
PLUR
Founded
1942
2001
Country
United States
Israel
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.2M
33.9M
IPO Year
1995
2001

Fundamental Metrics

Financial Performance
Metric
UG
PLUR
Price
$6.25
$3.06
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
2.8K
5.5K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
7.99%
N/A
EPS Growth
N/A
10.78
EPS
0.20
N/A
Revenue
$12,181,971.00
$1,336,000.00
Revenue This Year
N/A
$97.38
Revenue Next Year
N/A
$293.97
P/E Ratio
$32.40
N/A
Revenue Growth
11.91
309.82
52 Week Low
$5.58
$2.82
52 Week High
$9.88
$7.13

Technical Indicators

Market Signals
Indicator
UG
PLUR
Relative Strength Index (RSI) 40.87 38.54
Support Level $5.58 $2.91
Resistance Level $6.78 $3.42
Average True Range (ATR) 0.13 0.19
MACD -0.03 -0.04
Stochastic Oscillator 21.92 13.64

Price Performance

Historical Comparison
UG
PLUR

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Share on Social Networks: